UnitedHealth Stock Drags on Dow: Stock Market Today
Corporate earnings have dominated Wall Street's attention this week, but that changes on Wednesday.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered daily
Kiplinger Today
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more delivered daily. Smart money moves start here.
Sent five days a week
Kiplinger A Step Ahead
Get practical help to make better financial decisions in your everyday life, from spending to savings on top deals.
Delivered daily
Kiplinger Closing Bell
Get today's biggest financial and investing headlines delivered to your inbox every day the U.S. stock market is open.
Sent twice a week
Kiplinger Adviser Intel
Financial pros across the country share best practices and fresh tactics to preserve and grow your wealth.
Delivered weekly
Kiplinger Tax Tips
Trim your federal and state tax bills with practical tax-planning and tax-cutting strategies.
Sent twice a week
Kiplinger Retirement Tips
Your twice-a-week guide to planning and enjoying a financially secure and richly rewarding retirement
Sent bimonthly.
Kiplinger Adviser Angle
Insights for advisers, wealth managers and other financial professionals.
Sent twice a week
Kiplinger Investing Weekly
Your twice-a-week roundup of promising stocks, funds, companies and industries you should consider, ones you should avoid, and why.
Sent weekly for six weeks
Kiplinger Invest for Retirement
Your step-by-step six-part series on how to invest for retirement, from devising a successful strategy to exactly which investments to choose.
Stocks opened higher Tuesday, putting the S&P 500 and Nasdaq Composite on track for new record highs. But the main indexes had swung lower by lunchtime as market participants parsed the latest round of corporate earnings reports and looked ahead to tomorrow's conclusion of the July Fed meeting.
Among the day's biggest post-earnings movers was Novo Nordisk (NVO), which cratered 21.8% after the Danish drugmaker cut its outlook for 2025.
The company now expects revenue growth of 11% at the midpoint and operating profit growth of 13%, down from the 17% and 20% growth it had called for in May.
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The reduced guidance "is related to lower growth expectations for Wegovy in the U.S. obesity market, lower growth expectations for Ozempic in the U.S. GLP-1 diabetes market, as well as lower-than-expected penetration for Wegovy" in select markets, Novo Nordisk said in its earnings release.
Shortages of the company's popular weight-loss drugs allowed compounding pharmacies to produce knockoff versions of Wegovy, which increased competition and reduced demand.
In a separate statement, the company said that Maziar Mike Doustdar will replace outgoing CEO Lars Fruergaard Jorgensen, effective August 7.
Procter & Gamble warns of rising prices
Elsewhere on the earnings calendar, Procter & Gamble (PG) reported higher-than-expected fiscal fourth-quarter earnings of $1.48 per share on in-line revenue of $20.9 billion.
For fiscal 2026, the company expects net sales to be up 3% and earnings per share to grow 2% at the midpoint of their respective ranges. The outlook anticipates a $1 billion headwind from President Donald Trump's tariff policies.
PG also said it will raise prices on roughly a quarter of its products to mitigate the cost of tariffs.
On Monday, Procter & Gamble announced that Shailesh Jejurikar, its current chief operating officer, will succeed Jon Moeller as CEO, effective January 1, 2026.
UnitedHealth stock sinks on weak guidance
PG fell 0.3%, though it was hardly the worst-performing Dow Jones stock today. That honor went to UnitedHealth Group (UNH).
The blue chip stock sank 7.5% after the country's largest health insurer gave disappointing full-year guidance due in part to rising medical costs.
"When we prepared our 2025 Medicare Advantage offerings back in the first half of 2024, we significantly underestimated the accelerating medical trend and did not modify benefits or plan offerings sufficiently to offset the pressures we are now experiencing," said UnitedHealthcare CEO Tim Noel on the company's earnings call.
As for its second-quarter results, UnitedHealth reported lower-than-expected earnings of $4.08 per share on slightly higher revenue of $111.6 billion.
UNP, Norfolk Southern announce merger
In non-earnings news, Union Pacific (UNP) said it will buy fellow railroad Norfolk Southern (NSC) for $320 per NSC share. The cash-and-stock deal gives Norfolk an enterprise value of roughly $85 billion.
The merger, if approved by regulators, will create the country's first transcontinental railroad. UNP dropped 2.4% today, while NSC declined 3.0%.
As for the main indexes, the Dow Jones Industrial Average fell 0.5% to 44,632, the S&P 500 shed 0.3% to 6,370, and the Nasdaq Composite gave back 0.4% to 21,098.
Job openings decline ahead of the Fed
Ahead of tomorrow's Fed announcement, data from the Bureau of Labor Statistics showed that job openings edged down to 7.4 million in June from May's 7.7 million.
"The job market remained lackluster in June, largely because employers are operating under great uncertainty," says Elizabeth Renter, senior economist at NerdWallet. "When companies can't make predictions about the economy and therefore their operations, they tend to wait for more information."
In other words, many businesses are pausing hiring and firing plans until a clearer picture emerges on the tariff front.
And we're likely to hear the central bank echo this wait-and-see philosophy in Wednesday's policy statement and for Fed Chair Jerome Powell to issue a similar outlook in his press conference.
Indeed, Powell has made it clear that the Federal Reserve will stay data-dependent until it sees how tariffs impact inflation.
Related content
- What CEOs Say About President Trump and Fed Chair Powell
- Figma IPO: Should You Buy FIG Stock?
- When Is the Next Jobs Report?
-
5 Vince Lombardi Quotes Retirees Should Live ByThe iconic football coach's philosophy can help retirees win at the game of life.
-
The $200,000 Olympic 'Pension' is a Retirement Game-Changer for Team USAThe donation by financier Ross Stevens is meant to be a "retirement program" for Team USA Olympic and Paralympic athletes.
-
10 Cheapest Places to Live in ColoradoProperty Tax Looking for a cozy cabin near the slopes? These Colorado counties combine reasonable house prices with the state's lowest property tax bills.
-
Don't Bury Your Kids in Taxes: How to Position Your Investments to Help Create More Wealth for ThemTo minimize your heirs' tax burden, focus on aligning your investment account types and assets with your estate plan, and pay attention to the impact of RMDs.
-
Are You 'Too Old' to Benefit From an Annuity?Probably not, even if you're in your 70s or 80s, but it depends on your circumstances and the kind of annuity you're considering.
-
In Your 50s and Seeing Retirement in the Distance? What You Do Now Can Make a Significant ImpactThis is the perfect time to assess whether your retirement planning is on track and determine what steps you need to take if it's not.
-
Your Retirement Isn't Set in Stone, But It Can Be a Work of ArtSetting and forgetting your retirement plan will make it hard to cope with life's challenges. Instead, consider redrawing and refining your plan as you go.
-
The Bear Market Protocol: 3 Strategies to Consider in a Down MarketThe Bear Market Protocol: 3 Strategies for a Down Market From buying the dip to strategic Roth conversions, there are several ways to use a bear market to your advantage — once you get over the fear factor.
-
Dow Adds 1,206 Points to Top 50,000: Stock Market TodayThe S&P 500 and Nasdaq also had strong finishes to a volatile week, with beaten-down tech stocks outperforming.
-
The Best Precious Metals ETFs to Buy in 2026Precious metals ETFs provide a hedge against monetary debasement and exposure to industrial-related tailwinds from emerging markets.
-
For the 2% Club, the Guardrails Approach and the 4% Rule Do Not Work: Here's What Works InsteadFor retirees with a pension, traditional withdrawal rules could be too restrictive. You need a tailored income plan that is much more flexible and realistic.
